Cargando…

Identification of Attractive Drug Targets in Neglected-Disease Pathogens Using an In Silico Approach

BACKGROUND: The increased sequencing of pathogen genomes and the subsequent availability of genome-scale functional datasets are expected to guide the experimental work necessary for target-based drug discovery. However, a major bottleneck in this has been the difficulty of capturing and integrating...

Descripción completa

Detalles Bibliográficos
Autores principales: Crowther, Gregory J., Shanmugam, Dhanasekaran, Carmona, Santiago J., Doyle, Maria A., Hertz-Fowler, Christiane, Berriman, Matthew, Nwaka, Solomon, Ralph, Stuart A., Roos, David S., Van Voorhis, Wesley C., Agüero, Fernán
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2927427/
https://www.ncbi.nlm.nih.gov/pubmed/20808766
http://dx.doi.org/10.1371/journal.pntd.0000804
_version_ 1782185750093103104
author Crowther, Gregory J.
Shanmugam, Dhanasekaran
Carmona, Santiago J.
Doyle, Maria A.
Hertz-Fowler, Christiane
Berriman, Matthew
Nwaka, Solomon
Ralph, Stuart A.
Roos, David S.
Van Voorhis, Wesley C.
Agüero, Fernán
author_facet Crowther, Gregory J.
Shanmugam, Dhanasekaran
Carmona, Santiago J.
Doyle, Maria A.
Hertz-Fowler, Christiane
Berriman, Matthew
Nwaka, Solomon
Ralph, Stuart A.
Roos, David S.
Van Voorhis, Wesley C.
Agüero, Fernán
author_sort Crowther, Gregory J.
collection PubMed
description BACKGROUND: The increased sequencing of pathogen genomes and the subsequent availability of genome-scale functional datasets are expected to guide the experimental work necessary for target-based drug discovery. However, a major bottleneck in this has been the difficulty of capturing and integrating relevant information in an easily accessible format for identifying and prioritizing potential targets. The open-access resource TDRtargets.org facilitates drug target prioritization for major tropical disease pathogens such as the mycobacteria Mycobacterium leprae and Mycobacterium tuberculosis; the kinetoplastid protozoans Leishmania major, Trypanosoma brucei, and Trypanosoma cruzi; the apicomplexan protozoans Plasmodium falciparum, Plasmodium vivax, and Toxoplasma gondii; and the helminths Brugia malayi and Schistosoma mansoni. METHODOLOGY/PRINCIPAL FINDINGS: Here we present strategies to prioritize pathogen proteins based on whether their properties meet criteria considered desirable in a drug target. These criteria are based upon both sequence-derived information (e.g., molecular mass) and functional data on expression, essentiality, phenotypes, metabolic pathways, assayability, and druggability. This approach also highlights the fact that data for many relevant criteria are lacking in less-studied pathogens (e.g., helminths), and we demonstrate how this can be partially overcome by mapping data from homologous genes in well-studied organisms. We also show how individual users can easily upload external datasets and integrate them with existing data in TDRtargets.org to generate highly customized ranked lists of potential targets. CONCLUSIONS/SIGNIFICANCE: Using the datasets and the tools available in TDRtargets.org, we have generated illustrative lists of potential drug targets in seven tropical disease pathogens. While these lists are broadly consistent with the research community's current interest in certain specific proteins, and suggest novel target candidates that may merit further study, the lists can easily be modified in a user-specific manner, either by adjusting the weights for chosen criteria or by changing the criteria that are included.
format Text
id pubmed-2927427
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-29274272010-08-31 Identification of Attractive Drug Targets in Neglected-Disease Pathogens Using an In Silico Approach Crowther, Gregory J. Shanmugam, Dhanasekaran Carmona, Santiago J. Doyle, Maria A. Hertz-Fowler, Christiane Berriman, Matthew Nwaka, Solomon Ralph, Stuart A. Roos, David S. Van Voorhis, Wesley C. Agüero, Fernán PLoS Negl Trop Dis Research Article BACKGROUND: The increased sequencing of pathogen genomes and the subsequent availability of genome-scale functional datasets are expected to guide the experimental work necessary for target-based drug discovery. However, a major bottleneck in this has been the difficulty of capturing and integrating relevant information in an easily accessible format for identifying and prioritizing potential targets. The open-access resource TDRtargets.org facilitates drug target prioritization for major tropical disease pathogens such as the mycobacteria Mycobacterium leprae and Mycobacterium tuberculosis; the kinetoplastid protozoans Leishmania major, Trypanosoma brucei, and Trypanosoma cruzi; the apicomplexan protozoans Plasmodium falciparum, Plasmodium vivax, and Toxoplasma gondii; and the helminths Brugia malayi and Schistosoma mansoni. METHODOLOGY/PRINCIPAL FINDINGS: Here we present strategies to prioritize pathogen proteins based on whether their properties meet criteria considered desirable in a drug target. These criteria are based upon both sequence-derived information (e.g., molecular mass) and functional data on expression, essentiality, phenotypes, metabolic pathways, assayability, and druggability. This approach also highlights the fact that data for many relevant criteria are lacking in less-studied pathogens (e.g., helminths), and we demonstrate how this can be partially overcome by mapping data from homologous genes in well-studied organisms. We also show how individual users can easily upload external datasets and integrate them with existing data in TDRtargets.org to generate highly customized ranked lists of potential targets. CONCLUSIONS/SIGNIFICANCE: Using the datasets and the tools available in TDRtargets.org, we have generated illustrative lists of potential drug targets in seven tropical disease pathogens. While these lists are broadly consistent with the research community's current interest in certain specific proteins, and suggest novel target candidates that may merit further study, the lists can easily be modified in a user-specific manner, either by adjusting the weights for chosen criteria or by changing the criteria that are included. Public Library of Science 2010-08-24 /pmc/articles/PMC2927427/ /pubmed/20808766 http://dx.doi.org/10.1371/journal.pntd.0000804 Text en Crowther et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Crowther, Gregory J.
Shanmugam, Dhanasekaran
Carmona, Santiago J.
Doyle, Maria A.
Hertz-Fowler, Christiane
Berriman, Matthew
Nwaka, Solomon
Ralph, Stuart A.
Roos, David S.
Van Voorhis, Wesley C.
Agüero, Fernán
Identification of Attractive Drug Targets in Neglected-Disease Pathogens Using an In Silico Approach
title Identification of Attractive Drug Targets in Neglected-Disease Pathogens Using an In Silico Approach
title_full Identification of Attractive Drug Targets in Neglected-Disease Pathogens Using an In Silico Approach
title_fullStr Identification of Attractive Drug Targets in Neglected-Disease Pathogens Using an In Silico Approach
title_full_unstemmed Identification of Attractive Drug Targets in Neglected-Disease Pathogens Using an In Silico Approach
title_short Identification of Attractive Drug Targets in Neglected-Disease Pathogens Using an In Silico Approach
title_sort identification of attractive drug targets in neglected-disease pathogens using an in silico approach
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2927427/
https://www.ncbi.nlm.nih.gov/pubmed/20808766
http://dx.doi.org/10.1371/journal.pntd.0000804
work_keys_str_mv AT crowthergregoryj identificationofattractivedrugtargetsinneglecteddiseasepathogensusinganinsilicoapproach
AT shanmugamdhanasekaran identificationofattractivedrugtargetsinneglecteddiseasepathogensusinganinsilicoapproach
AT carmonasantiagoj identificationofattractivedrugtargetsinneglecteddiseasepathogensusinganinsilicoapproach
AT doylemariaa identificationofattractivedrugtargetsinneglecteddiseasepathogensusinganinsilicoapproach
AT hertzfowlerchristiane identificationofattractivedrugtargetsinneglecteddiseasepathogensusinganinsilicoapproach
AT berrimanmatthew identificationofattractivedrugtargetsinneglecteddiseasepathogensusinganinsilicoapproach
AT nwakasolomon identificationofattractivedrugtargetsinneglecteddiseasepathogensusinganinsilicoapproach
AT ralphstuarta identificationofattractivedrugtargetsinneglecteddiseasepathogensusinganinsilicoapproach
AT roosdavids identificationofattractivedrugtargetsinneglecteddiseasepathogensusinganinsilicoapproach
AT vanvoorhiswesleyc identificationofattractivedrugtargetsinneglecteddiseasepathogensusinganinsilicoapproach
AT aguerofernan identificationofattractivedrugtargetsinneglecteddiseasepathogensusinganinsilicoapproach